Ken Umehara
Tokushima Research Institute
Otsuka Pharmaceutical Co.
Ltd., Tokushima
Japan
Name/email consistency: high
- Oxidative one-carbon cleavage of the octyl side chain of olanexidine, a novel antimicrobial agent, in dog liver microsomes. Umehara, K., Shimokawa, Y., Koga, T., Ohtani, T., Miyamoto, G. Xenobiotica (2004)
- Effect of gamma-oryzanol on cytochrome P450 activities in human liver microsomes. Umehara, K., Shimokawa, Y., Miyamoto, G. Biol. Pharm. Bull. (2004)
- Inhibition of human drug metabolizing cytochrome P450 by buprenorphine. Umehara, K., Shimokawa, Y., Miyamoto, G. Biol. Pharm. Bull. (2002)
- Effect of probucol on cytochrome P450 activities in human liver microsomes. Umehara, K., Shimokawa, Y., Miyamoto, G. Biol. Pharm. Bull. (2002)
- Oxidative cleavage of the octyl side chain of 1-(3,4-dichlorobenzyl)-5-octylbiguanide (OPB-2045) in rat and dog liver preparations. Umehara, K., Kudo, S., Hirao, Y., Morita, S., Uchida, M., Odomi, M., Miyamoto, G. Drug Metab. Dispos. (2000)
- In vitro characterization of the oxidative cleavage of the octyl side chain of olanexidine, a novel antimicrobial agent, in dog liver microsomes. Umehara, K., Kudo, S., Hirao, Y., Morita, S., Ohtani, T., Uchida, M., Miyamoto, G. Drug Metab. Dispos. (2000)